GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CES1, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, HTR2A, HTR2B, HTR5A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
16.2337 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, GSK3B, HSD17B2, HTR5A, IDO1, IGF1R, INSR, MMP2, MMP9, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TEK, TYR |
15.4524 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, HTR1A, HTR2A, HTR2B, IDO1, IGF1R, INSR, KDR, MAP2K1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
15.4524 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, HTR5A, IDO1, IGF1R, INSR, KDR, MMP2, PPARA, PTGES, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
14.9433 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
14.6365 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
14.621 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, HTR5A, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TEK, TYR |
13.3072 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KCNH2, KDR, MAOA, MET, PPARA, PTGS2, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
12.3125 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
12.1746 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
11.9752 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
11.8245 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DHFR |
11.6406 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, HTR5A, IDO1, PTGES, PTGS2, RELA, RORC, SLC6A4, SRC, TYR |
11.6267 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CES1, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
11.4029 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MAP2K1, MAP3K7, MET, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
11.2534 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, ADRA2A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ESR1, ESRRA, FABP3, FLT3, GSK3B, HTR5A, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK |
11.2131 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, FABP3, FUT7, HSD17B3, HSPA1A, HTR2B, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR, XDH |
11.1259 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.9223 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, HTR6, IDO1, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
10.8871 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8666 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IDO1, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
10.6093 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
10.4163 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
10.2414 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, ADRA2A, AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HTR5A, INSR, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK |
9.86154 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, RELA, TEK, TERT |
9.82519 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KCNH2, KDR, PTGS2, RELA, SLC6A2, SLC6A4, SRC |
9.8127 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.74725 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
9.72813 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
9.66323 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
9.6015 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CNR1, CNR2, CYP19A1, DHFR, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, GSK3B, HSPA1A, IDO1, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
9.44285 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, ADRA2A, AR, BCL2, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
9.36125 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, ADRA2A, AR, BCL2, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, GSK3B, HSPA1A, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
9.33674 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B2, HSD17B3, MET, PPARA, PTGES, PTGS2 |
9.25504 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC, TEK |
9.25504 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, GSK3B, HCAR2, HSPA1A, HTR2A, HTR2B, IDO1, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.16242 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GSK3B, HCAR2, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTGS2, PTPN1, RELA, SIGMAR1, SMAD3, SRC, TEK, TERT, XDH |
9.16242 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS2 |
8.95854 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, ADRA2A, APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HCAR2, HSPA1A, HTR2A, HTR2B, IDO1, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, TERT |
8.95854 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.9453 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CES1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, INSR, KDR, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SIGMAR1, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
8.76348 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.7116 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, HTR6, IDO1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.7116 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS2 |
8.68331 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS2 |
8.5637 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
8.49985 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
8.49985 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
8.46254 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.43045 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, KCNH2, MAP2K1, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT |
8.27543 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
8.20327 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGES, PTGS2, RELA, SRC, TERT |
8.19401 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2A, HTR2B, INSR, KCNH2, MET, SMAD3, SRC, TERT |
8.1613 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
8.03886 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DHFR, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK, TYR |
8.03264 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, HSD17B2, HSD17B3 |
8.03264 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2A, HTR2B, KDR, PTGS2, SRC |
8.03264 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
8.02293 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.02293 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, EGFR, ESRRB, FABP3, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.02293 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, GSK3B, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SIGMAR1, SMAD3, SRC, TEK |
8.02293 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ADRA2A, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.02293 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, HTR2A, PTGS2, SLC6A4 |
8.00944 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, HTR2A, PTGS2, SLC6A4 |
8.00944 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
8.0008 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
8.0008 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
7.99771 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4, SRC, TEK |
7.97767 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
7.96791 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, EGFR, GSK3B, HSPA1A, HTR2B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.95542 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, MAOA, PTGS2, SLC6A2, SLC6A4, SMAD3 |
7.93126 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, ADRA2A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, KCNH2, MET, SMAD3 |
7.91409 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.80535 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.75375 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.73187 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, HSD17B3, HTR5A, INSR, KDR, MAP2K1, MMP9, PIM1, PPARA, PTGS2, RELA, RORC, SIGMAR1, SMAD3, SRC, TEK, TYR |
7.73187 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
7.73187 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, APP, AR, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, PTPN1, SRC, TEK, XDH |
7.6324 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, CNR1, CNR2, DHFR, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, GSK3B, IGF1R, INSR, MMP2, PPARA, PTGS2, RELA, SLC6A4, SRC, TEK, TYR |
7.52702 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CNR1, DRD2, DRD3, GPR35, HTR2A, KCNH2, MMP9, PTGS2 |
7.47871 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, MMP2, PPARA, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
7.43361 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.43361 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, EGFR, HSPA1A, IDO1, MAOA |
7.43251 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPR35, GSK3B, HCAR2, HSPA1A, HTR2A, HTR2B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.40256 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CES1, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, RELA, SLC6A4, SRC |
7.35414 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, CNR1, CNR2, DRD2 |
7.33943 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.28328 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
7.2668 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
7.24257 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, HSD17B3, HTR1A, MAOA, TYR |
7.19508 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGES, PTGS2 |
7.1857 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, GSK3B, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.1857 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, DHFR, DRD2, EGFR, ESR1, ESR2, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.17498 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, IDO1, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, SMAD3, TEK |
7.1502 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS2 |
7.10348 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, CNR1, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.07722 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, GSK3B, HCAR2, HTR2B, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT |
7.07043 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CNR1, CYP1A1, DRD3, FABP3, FLT3, HCAR2, HTR2A, HTR2B, PPARA, PTGS2, RORC, SRC, TEK |
7.04816 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ADRA2A, APP, AR, DRD2, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, PTPN1, SRC, TEK, XDH |
7.01418 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.95468 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.93088 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
6.91559 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.91559 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD2, EGFR, ESRRB, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
6.88135 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.88015 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD17B2, HSD17B3, HTR1A, HTR2A |
6.86812 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.85619 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.84753 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.8259 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
6.72877 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2, HTR2A, PTGS2, SLC6A4 |
6.71191 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
6.68449 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.66509 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
6.63722 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, INSR, KDR, MMP2, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC |
6.63168 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, HTR2B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
6.62477 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, GPR35, HTR1A, HTR2A, KCNH2, MMP9, PTGS2, SLC6A4 |
6.60181 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.56127 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.56127 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
6.55682 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.52504 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES, PTGS2 |
6.51923 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, GSK3B, HTR7, PPARA, RORC, SLC6A4, SRC |
6.502 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, IDO1, MAP3K7, MMP12, MMP2, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK |
6.43416 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA, PTGES, PTGS2 |
6.42017 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.32492 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
6.32492 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, GSK3B, HSD17B2, HSD17B3, IDO1, MAOA, PTGS2, TYR, XDH |
6.25453 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
6.25453 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
6.19767 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, CHRM2, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
6.18354 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, ESR1, GPR35, GSK3B, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, SIGMAR1, SRC |
6.18272 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.18205 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
6.11737 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
6.10778 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7, SLC6A4 |
6.07808 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, RORC |
6.06689 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, FABP3, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
6.03263 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, ADRA2A, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, GSK3B, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PTPN1, RELA, SRC, TEK |
6.02927 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, ADRA2A, APP, AURKB, BCL2, CDC25B, DHFR, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.02447 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.00989 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.99169 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, RELA, SRC, TEK, XDH |
5.92186 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, EGFR, PTGS2 |
5.85751 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.85132 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, PTGS2, SLC6A4 |
5.81106 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP2D6, DHFR, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
5.78005 |
[BP] GO:0007200 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2B |
5.76581 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, DUSP3, EGFR, HTR2A, HTR2B, KDR, MAP2K1, PTPN1, SRC, TEK |
5.73556 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, IDO1, MAP2K1, PTGES, PTGS2, SLC6A4, SMAD3, TERT, XDH |
5.72912 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, HTR2B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
5.6942 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
5.65868 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, EGFR, HTR2A, PTGS2 |
5.64357 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, IDO1, PPARA, PTGES, PTGS2 |
5.63303 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.61177 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.61177 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, ADRA2A, AR, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TERT, XDH |
5.59012 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
5.54362 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.51862 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, PTGS2, RORC, SLC6A4, SRC |
5.5174 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.48146 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CNR1, CSNK2A1, EGFR, ESRRB, GSK3B, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PPARA, PTPN1, RELA, SMAD3 |
5.45457 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
5.42625 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.39116 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.32745 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DRD1, EGFR, ESR1, GSK3B, IGF1R, INSR, MMP2, MMP9, PTGS2, RELA, RORC, SLC6A4, SRC |
5.31762 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, RELA, SRC, XDH |
5.23684 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CACNA1C, CHRM2, DRD2, DRD3, EGFR, GPR35, HCAR2, HTR2A, KCNH2, PTGS2, SMAD3 |
5.21694 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, IDO1, INSR, MAP2K1, MMP2, MMP9, PTGS2, SLC6A4, SRC |
5.19312 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, DRD1, EGFR, ESR1, FLT3, GSK3B, IGF1R, INSR, MMP2, PTGS2, RELA, SLC6A4, SMAD3, SRC |
5.18981 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, EGFR, GSK3B, HSPA1A, HTR1A, IDO1, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PPARA, PTGES, PTGS2, PTPN1, RELA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.177 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
5.17488 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, EGFR, HTR2A, HTR2B, KDR, MAP2K1, SRC, TEK |
5.17355 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, HTR2B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.17119 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, CNR1, DRD2, DRD3, PPARA, PTGS2, SMAD3 |
5.15235 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
5.10782 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGES, PTGS2, TERT |
5.08678 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, RELA, SMAD3, TEK |
5.05745 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GSK3B, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, TYR, XDH |
5.05592 |
[BP] GO:0050999 |
None
|
CNR1, CNR2, DHFR, EGFR, HTR2B, TERT |
5.05353 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, PTGS2, RELA, SLC6A4, SRC |
5.05016 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, ADRA2A, AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, HTR7, INSR, KCNH2, PTGS2, SLC6A4, SRC, TEK, TYR |
5.04233 |
[BP] GO:0007610 |
None
|
APP, BCL2, CNR1, DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, IDO1, INSR, PPARA, PTGS2, SLC6A4 |
5.0237 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, CNR1, EGFR, HCAR2, HTR2B, MET, PPARA, RELA, SMAD3 |
5.01004 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
4.99521 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
4.95513 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, CNR1, DRD1, DRD2, DRD3, HTR2A |
4.95337 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
4.92789 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.92154 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, CACNA1C, CNR1, DRD2, DRD3, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC |
4.87908 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR, PTGS2, SLC6A4 |
4.87712 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTGS2, PTPN1, SRC, TEK, XDH |
4.85165 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
4.84788 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGES, PTGS2, RELA, SRC |
4.80291 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, GSK3B, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
4.79392 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
4.72321 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, BCL2, CACNA1C, CNR1, CSNK2A1, DRD2, DRD3, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT |
4.70908 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, PTGS2, SRC, TEK |
4.70792 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, ADRA2A, APP, BCL2, CNR1, DRD2, DRD3, GPR35, GSK3B, HSPA1A, HTR2A, KCNH2, MMP9, PTGS2 |
4.69791 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CACNA1C, CHRM2, DRD2, EGFR, HTR2A, KCNH2, PTGS2 |
4.69115 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, HCAR2, PTGS2 |
4.67523 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, RORC, SMAD3, SRC, TERT |
4.6625 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GSK3B, HTR2A, IDO1, INSR, KDR, MAP2K1, NUAK1, PIM1, PPARA, PTGS2, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.62727 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
4.62329 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CNR1, CYP1A1, HTR2A, MAP2K1, PTGS2, RELA, TERT |
4.59917 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F3, HTR2A, IDO1, INSR, KDR, MAP2K1, PIM1, PTGS2, RELA, SMAD3, SRC, TEK, TERT |
4.55716 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.55716 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
4.55716 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, PTGES, PTGS2, RELA, SRC |
4.54793 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.54793 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DHFR, DRD2, EGFR, PPARA, SMAD3 |
4.54786 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, ADRA2A, CACNA1C, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
4.5435 |
[BP] GO:0007611 |
None
|
APP, CNR1, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR, PTGS2, SLC6A4 |
4.5435 |
[BP] GO:0032768 |
None
|
CNR1, CNR2, DHFR, EGFR, HTR2B, TERT |
4.53103 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
4.53103 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, PTGS2, SRC |
4.50562 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, AXL, BCL2, CACNA1C, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, PTGS2, SLC6A2, TEK |
4.49992 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
4.49967 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.49051 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CNR1, DRD2, DRD3, ESR1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.48912 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
4.46936 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, RELA, SMAD3, TYR |
4.44215 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, GSK3B, HTR7, PPARA, RORC, SLC6A4 |
4.42154 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, CACNA1C, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, KCNH2, SLC6A2, TEK |
4.41279 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
4.40735 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.40202 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.40202 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, KCNH2, PPARA, SLC6A2, SLC6A4 |
4.36495 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
4.3607 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA1A, ADRA2A, APP, AR, BCL2, CDC25B, CSNK2A1, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.3471 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.29419 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.28835 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, PTGS2, RELA, RORC, SMAD3, SRC, TERT |
4.28835 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, GSK3B, IDO1, INSR, KDR, MAP2K1, PIM1, PTGS2, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.28835 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.27338 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, GPR35, HTR2A, HTR2B, KCNH2, SMAD3 |
4.27338 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
4.24651 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2B, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
4.23346 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
4.23346 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, RELA, SLC6A4, SRC |
4.21318 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, HTR2B, IDO1, MAP3K7, MMP12, PTGS2, RELA, SMAD3, SRC |
4.21318 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
4.18011 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR, HTR6 |
4.17929 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, APP, BCL2, CACNA1C, CNR1, DRD2, DRD3, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC |
4.1754 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, BCL2, CACNA1C, CNR1, CNR2, DRD1, GPR35, KCNH2, KDR, SRC |
4.16158 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, MMP12, SLC6A4, SRC |
4.15749 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
4.15108 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
4.12324 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
4.11946 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT |
4.11565 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1, TERT |
4.1015 |
[BP] GO:0007613 |
None
|
CNR1, DRD1, DRD2, HTR2A, INSR, PTGS2, SLC6A4 |
4.10094 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
4.09417 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, HTR1A, MAP2K1, MET, PIM1, SRC, TEK, TYR |
4.08504 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
4.05903 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR |
4.05243 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, HTR2A, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT |
4.03387 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HSD17B3 |
4.02924 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
4.02924 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, HSPA1A, MMP9, PTGS2, PTPN1, RELA, SRC, TERT |
4.02681 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
4.01661 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS2, RELA, SRC |
4.00204 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT |
4.00204 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
3.98806 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.98731 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, HTR2A, HTR2B, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
3.93561 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, INSR, PPARA, PTGS2, RELA, SRC, TEK |
3.93561 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2, TYR |
3.91929 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
3.91621 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC, TEK |
3.91621 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KCNH2, KDR, PTGS2, RELA, SRC |
3.91447 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, EGFR, FLT3, PTGS2, RELA, SRC |
3.91178 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, DRD3, EGFR, HTR2A, IDO1, MMP12, PTGES, PTGS2, RELA, SLC6A4, SMAD3, SRC, TYR |
3.90731 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, EGFR, GSK3B, IGF1R, INSR, MMP2, PTGS2, RELA, SLC6A4, SRC |
3.89876 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, PTGS2, RELA, TYR |
3.87973 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, BCL2, CACNA1C, DRD1, DRD2, DRD3, GPR35, HTR2A, KCNH2, PTGS2 |
3.87829 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
3.87266 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CNR1, CSNK2A1, CYP2D6, DHFR, DRD2, DRD3, DUSP3, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, HTR2B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
3.85414 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, HTR2B, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
3.85414 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, HTR2A, HTR2B, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
3.8539 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, APP, CACNA1C, CNR1, DRD2, DRD3, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.84644 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.83622 |
[BP] GO:0045776 |
None
|
ADORA1, CNR1, DRD2, DRD3, PPARA |
3.83357 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, AR, BCL2, CACNA1C, CSNK2A1, DRD1, DRD2, DRD3, EGFR, GSK3B, MAP2K1, PTGS2, PTPN1, SMAD3, SRC, TERT |
3.82734 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, DHFR, EGFR, INSR, PTGS2, SMAD3, XDH |
3.80136 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.8004 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.79524 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.78909 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.78909 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
3.76944 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.7432 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ADRA2A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, PTGS2, SLC6A4 |
3.73897 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, RELA, SRC |
3.7193 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, CNR1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
3.68458 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, HTR5A, PTGS2, SLC6A4 |
3.68061 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR |
3.65979 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, CHRM2, CNR1, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, SLC6A2, TEK |
3.65177 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, RELA, TYR |
3.62479 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, BCL2, GSK3B, HSPA1A, MMP9, PTGS2, PTPN1, RELA, SMAD3, SRC, TERT |
3.61676 |
[BP] GO:0050433 |
None
|
ADRA2A, CNR1, DRD2, DRD3, HTR2A |
3.61184 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.61184 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SLC6A4, SRC |
3.60944 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.60766 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.60224 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, CNR1, HCAR2 |
3.58796 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2, HSD17B3 |
3.54101 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.53019 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, CNR1, DRD2 |
3.51133 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, GSK3B, IDO1, MMP12, PTGES, PTGS2, RELA, SMAD3, SRC |
3.47081 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, DHFR, HTR1A, MAOA, SLC6A4 |
3.46335 |
[BP] GO:0051341 |
None
|
CNR1, CNR2, DHFR, EGFR, HTR2B, TERT |
3.46335 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.46172 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.43957 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, HTR2A, MET |
3.43824 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT |
3.42938 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TERT |
3.42108 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, EGFR, PTGS2, RELA, SLC6A4, TYR |
3.41824 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, CNR1, HCAR2, PPARA |
3.41351 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.40576 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.40513 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.3993 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.3993 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
3.39702 |
[BP] GO:0019933 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.39453 |
[BP] GO:0098900 |
None
|
ADRA1A, CACNA1C, CNR1, CNR2, GPR35 |
3.38112 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, IDO1, MAP3K7, MMP12, MMP2, PTPN1, RELA, SMAD3, SRC |
3.36586 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, IDO1, SLC6A2 |
3.34288 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.32481 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.31848 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.31472 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
3.29836 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, HTR2A, HTR2B, SRC |
3.29836 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.29782 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.29734 |
[BP] GO:0031349 |
positive regulation of defense response
|
CNR1, EGFR, FABP4, HSPA1A, IDO1, MAP3K7, MMP12, MMP2, PTGS2, RELA, SRC |
3.28066 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK |
3.28066 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.27432 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, RELA |
3.26558 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, BCL2, CA2, CA9, CACNA1C, CYP1B1, DRD2, EGFR, ESR1, HTR2B, INSR, MET, MMP2, RELA, SLC6A4, SMAD3, SRC, TEK |
3.25049 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.24538 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, CACNA1C, CNR1, DRD2, DRD3, EGFR, HCAR2, HTR2B, MMP12, SRC |
3.22948 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, HTR2A, KCNH2 |
3.22908 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.19754 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3, HTR2A |
3.19754 |
[BP] GO:0019935 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3, HTR5A |
3.18282 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.18282 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, DRD2, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, SMAD3, SRC |
3.17664 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.1756 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, DRD2, DRD3, EGFR, ESRRA, ESRRB, GSK3B, HTR2A, KDR, MAP2K1, PPARA, PTGS2, RELA, RORC, SLC6A4, SMAD3, TERT, XDH |
3.17241 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, MET, SRC, TEK |
3.16729 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, PTGS2, RELA, SLC6A4, SRC, TYR |
3.16729 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.16729 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.16729 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.16729 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, HTR2A, MET, SRC |
3.16729 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.16687 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F3, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
3.16687 |
[BP] GO:0019229 |
None
|
ADRA1A, ADRA2A, EGFR, HTR2A, PTGS2 |
3.14981 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
3.13196 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.1295 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.12655 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, GSK3B, KDR, SMAD3, SRC, TEK |
3.12655 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, RELA, SRC, TERT |
3.12655 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.11394 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, BCL2, CA2, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.11387 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, IDO1, MMP12, PTGES, PTGS2, RELA, SMAD3, SRC |
3.11387 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
3.10349 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, DRD2, HSPA1A, HTR2B, IDO1, MAP3K7, MMP12, PTGS2, RELA, SMAD3, SRC |
3.09067 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
3.09067 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.08238 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MAP2K1, MET, MMP1, MMP12, MMP9, SRC, TEK |
3.07948 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MAP2K1, MMP1, MMP12, MMP9, SRC, TEK |
3.07948 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, GSK3B, HSPA1A, HTR2A, INSR, KDR, MAP3K7, PPARA, PTPN1 |
3.06772 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.04831 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.04831 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.04751 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
3.0327 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.02659 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, ADRA2A, CHRM2, PTGS2 |
3.00354 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, GPR35, PTGS2 |
3.00354 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.00339 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, DRD3, RELA |
3.00339 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, DRD3, RELA |
3.00339 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.00339 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.00339 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CHRM2, CYP1A1, DRD3, EGFR, HSPA1A, HTR2A, IDO1, INSR, KDR, MAP2K1, MET, MMP1, MMP12, RELA, SLC6A4, SMAD3, SRC |
2.99834 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CES1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GSK3B, HTR2B, KDR, MAP2K1, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SRC, TEK, TERT |
2.99403 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP12, MMP9, SRC, TEK |
2.97166 |
[BP] GO:0099536 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.96403 |
[BP] GO:0099537 |
None
|
CHRM2, CNR1, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.96403 |
[BP] GO:1902893 |
None
|
PPARA, RELA, SMAD3, TERT |
2.95663 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
2.95663 |
[BP] GO:0045907 |
None
|
ADRA1A, EGFR, HTR2A, PTGS2 |
2.95663 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SIGMAR1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.94711 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CNR1, CYP1A1, DRD1, EGFR, ESR1, PTGS2, SLC6A4, SRC |
2.94436 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, HTR2A, PTPN1, SRC |
2.93783 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, INSR, PPARA, SRC |
2.92371 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.92277 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2C19, CYP2D6, MAOA |
2.91562 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
2.91562 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
2.90418 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3, IDO1 |
2.9013 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.9013 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.9013 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.9013 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, PPARA, SMAD3, TEK |
2.90047 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.88782 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A4, SMAD3 |
2.88415 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.87466 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, MAP3K7, PIM1, RELA |
2.86914 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRA1A, APP, CSNK2A1, DRD2, EGFR, ESR1, F3, GSK3B, HSPA1A, HTR2A, HTR2B, MMP9, NUAK1, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.85223 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GSK3B, HTR2A, INSR, PPARA, RORC, SRC |
2.85201 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
2.84526 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, TEK |
2.83874 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.82985 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, ESRRB, HTR2A, INSR, PPARA |
2.82905 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, EGFR, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.82651 |
[BP] GO:0007189 |
None
|
ADRA1A, ADRA2A, DRD1, DRD2, DRD3 |
2.82625 |
[BP] GO:0031331 |
positive regulation of cellular catabolic process
|
ADRA2A, ESRRB, GSK3B, HSPA1A, HTR2A, INSR, KDR, MAP3K7, PPARA, PTPN1 |
2.81219 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, DRD2, EGFR, GSK3B, HCAR2, HTR2B, MMP12, PTGS2, SMAD3, SRC |
2.80761 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.8075 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.8075 |
[BP] GO:0033604 |
None
|
ADRA2A, CNR1, DRD2 |
2.8075 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, RELA, SRC |
2.80117 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
2.79512 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, GSK3B |
2.79124 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.79124 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, GPR35, HTR2A, HTR2B |
2.75295 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.75157 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.7489 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.7489 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GSK3B, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
2.74661 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADORA1, ADRA1A, APP, AXL, BCL2, DRD2, DRD3, EGFR, GPR35, GSK3B, IDO1, PTGS2, SLC6A4, SMAD3, TEK, TERT, XDH |
2.73618 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CNR1, CYP1A1, EGFR, PTGS2, RELA, SLC6A4, SRC, TYR |
2.73523 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, APP, CNR1, CNR2, CSNK2A1, DRD2, DRD3, DUSP3, FABP4, GSK3B, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.72969 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B |
2.72969 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.72678 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.71965 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.71965 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.71965 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
ADRA2A, BCL2, CNR1, ESRRB, GSK3B, HSPA1A, HTR2A, HTR2B, INSR, KDR, MAP3K7, MET, PPARA, PTPN1 |
2.7168 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, GPR35, HTR2A, HTR2B, SMAD3 |
2.69972 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, HTR2B, KDR, MMP12, SMAD3, TEK, XDH |
2.6845 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.68269 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
2.67738 |
[BP] GO:0051254 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.6441 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
2.64384 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, PTGS2, RELA, SLC6A4, TEK, TYR |
2.64384 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.639 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.639 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.639 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.639 |
[BP] GO:0035094 |
response to nicotine
|
BCL2, CNR1, DRD2, RELA |
2.639 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.639 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, PTGS2, RELA, TYR |
2.60716 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.60045 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.60045 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, RELA, TYR |
2.59746 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.59227 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.58973 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.57173 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, APP, AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MAP2K1, MMP1, MMP12, MMP9, PTGS2, SRC, TEK |
2.56169 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.56169 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.56169 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.55537 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, EGFR, FLT3 |
2.55467 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, INSR, PTGS2 |
2.55467 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.55467 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, DRD3, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.54582 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, ESR1, HTR2A, HTR2B |
2.53242 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.52938 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.52938 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.52938 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52938 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.52938 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.52938 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.52938 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK |
2.52938 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.51733 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.50696 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.50696 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
2.50354 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.50011 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CES1, CYP19A1, CYP1A1, DHFR, HSD17B3, IDO1, PTGES, PTGS2 |
2.49589 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.48523 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.47872 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, MMP12, SLC6A4, SRC |
2.47872 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, RELA, RORC, SLC6A4, SRC |
2.47872 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, DRD3, RELA |
2.47872 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, DHFR, SLC6A4 |
2.47737 |
[BP] GO:0045893 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.4751 |
[BP] GO:1903508 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.4751 |
[BP] GO:1902680 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.47177 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.46962 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.45961 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, INSR, RELA, SRC |
2.44489 |
[BP] GO:0051588 |
None
|
DRD1, DRD2, DRD3, HTR1A, SLC6A4 |
2.43891 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.43891 |
[BP] GO:0051000 |
None
|
DHFR, HTR2B, TERT |
2.4354 |
[BP] GO:0045821 |
None
|
ESRRB, HTR2A, INSR |
2.4354 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.4354 |
[BP] GO:0014074 |
response to purine-containing compound
|
APP, PTGS2, RELA, SLC6A4, TEK, TYR |
2.41574 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.4146 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.38612 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, KCNH2 |
2.37671 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.36959 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.36959 |
[BP] GO:0051197 |
None
|
ESRRB, HTR2A, INSR |
2.36959 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DHFR, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.36756 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, GSK3B, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SIGMAR1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.34981 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.33797 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, SLC6A2 |
2.33797 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2 |
2.31911 |
[BP] GO:0023014 |
signal transduction by protein phosphorylation
|
EGFR, HTR2B, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, TEK |
2.31099 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.307 |
[BP] GO:0071880 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.307 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, F3, KDR, PTGS2, TEK, TERT |
2.30146 |
[BP] GO:1900180 |
regulation of protein localization to nucleus
|
APP, EGFR, GSK3B, PTGS2, SMAD3, SRC, TERT |
2.30005 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CNR1, CYP1B1, F3, GSK3B, HCAR2, IDO1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.29562 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.29289 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.29289 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, PTGS2, SRC |
2.2903 |
[BP] GO:2001236 |
regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, HSPA1A, RELA, SRC, TERT |
2.2903 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.28531 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.27247 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.27247 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.27247 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.27077 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.2695 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CYP1B1, DUSP3, GSK3B, IDO1, KDR, MAP3K7, NUAK1, PPARA, SMAD3, SRC, TEK |
2.25821 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.25757 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.25757 |
[BP] GO:0051968 |
None
|
DRD1, EGFR, PTGS2 |
2.25757 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.25757 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.25655 |
[BP] GO:0051924 |
regulation of calcium ion transport
|
ADRA2A, BCL2, CACNA1C, DRD1, DRD2, GPR35, PTGS2 |
2.25636 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.25636 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.24456 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.24456 |
[BP] GO:0022898 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, GPR35, MMP9 |
2.2358 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA1A, ADRA2A, CACNA1C, CHRM2, PTGS2, SMAD3 |
2.2358 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.22002 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA1A, ADRA2A, CACNA1C, CHRM2, PTGS2 |
2.21816 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.21816 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.21816 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CNR1, CNR2, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR, PTGS2, SLC6A4, TYR |
2.2113 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CES1, CYP19A1, DHFR, HSD17B3, TYR |
2.20822 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.20822 |
[BP] GO:1902895 |
None
|
RELA, SMAD3, TERT |
2.20822 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.20822 |
[BP] GO:0051194 |
None
|
ESRRB, HTR2A, INSR |
2.20822 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.20822 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DHFR, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MMP12, MMP9, PPARA, PTGS2, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.20179 |
[BP] GO:0045597 |
positive regulation of cell differentiation
|
APP, AR, AXL, BCL2, CA2, CNR1, DRD2, HTR2A, KDR, MAP2K1, PTGS2, RELA, SMAD3, TERT |
2.20157 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.19429 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, AR, BCL2, DRD2, DRD3, INSR, PIM1, SLC6A4 |
2.18564 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, HTR2B, MMP12, SRC |
2.16831 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, DRD3, RELA |
2.16831 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.16831 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.16831 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PTGS2, SMAD3, SRC, XDH |
2.15917 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.15762 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15762 |
[BP] GO:0032989 |
cellular component morphogenesis
|
APP, AR, AXL, BCL2, DRD2, EGFR, MET, SRC, TEK |
2.15151 |
[BP] GO:0008016 |
None
|
ADORA1, ADORA3, ADRA1A, CACNA1C, CHRM2, DRD2, KCNH2 |
2.15118 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, MAP2K1, TEK, TYR |
2.14906 |
[BP] GO:0046328 |
regulation of JNK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP3K7, PTPN1 |
2.12305 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, DRD2, DUSP3, IDO1, MMP12 |
2.11556 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.10893 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.10893 |
[BP] GO:0071875 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.10893 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.10893 |
[BP] GO:0032409 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, GPR35, MMP9 |
2.1023 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AXL, BCL2, CA2, CA9, CYP1B1, DHFR, EGFR, GSK3B, HSPA1A, MAP2K1, MAP3K7, MMP9, NUAK1, PTGS2, PTPN1, RELA, SRC, TERT |
2.1002 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, MAP3K7, RELA |
2.09522 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.09522 |
[BP] GO:0099565 |
chemical synaptic transmission, postsynaptic
|
DRD2, GSK3B |
2.09522 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.09522 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.09522 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.09522 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.09522 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.09522 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.09522 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.09447 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, HTR2A, PTPN1, SRC |
2.08155 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.0801 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
2.0801 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.07696 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B2, HSD17B3 |
2.07696 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, GSK3B, HSPA1A, IDO1, MAOA, SRC, XDH |
2.07608 |
[BP] GO:0032770 |
None
|
DHFR, HTR2B, TERT |
2.06939 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.06939 |
[BP] GO:1903827 |
regulation of cellular protein localization
|
APP, AR, BCL2, CSNK2A1, EGFR, GSK3B, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.06215 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, PTGS2, TEK, TERT |
2.06027 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.05339 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B |
2.05226 |
[BP] GO:0050729 |
positive regulation of inflammatory response
|
CNR1, EGFR, FABP4, IDO1, PTGS2 |
2.03514 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.02615 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.02615 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.02615 |
[BP] GO:0006693 |
None
|
CES2, PTGES, PTGS2 |
2.02615 |
[BP] GO:0006692 |
None
|
CES2, PTGES, PTGS2 |
2.02615 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.02615 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT |
2.02615 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, GSK3B, HSPA1A, IDO1, MAOA, XDH |
2.02255 |
[BP] GO:0046889 |
None
|
FABP3, HTR2A, HTR2B, PTGS2 |
2.00875 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA4, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK |
8.10862 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SLC6A2, SLC6A4, TEK |
7.29312 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, GPR35, GSK3B, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
6.95468 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ADRA2A, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FLT3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PTGS2, SIGMAR1, SLC6A2, SLC6A4, SRC, TEK |
6.76707 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
6.33742 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
5.45289 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
5.42659 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MAOA, MET, PTGES, PTGS2, PTPN1, SIGMAR1, SLC6A2, SLC6A4, SRC, TEK, TYR |
4.7955 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, APP, CNR1, EGFR, HTR2A, INSR, KDR, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
4.65261 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HSD17B3, HSPA1A, HTR5A, KDR, MAP2K1, PTGS2, PTPN1, SIGMAR1, XDH |
4.05417 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, EGFR, FLT3, HSD17B2, HSD17B3, PTGES, PTGS2, PTPN1, SIGMAR1 |
3.89541 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, ADRA2A, CA2, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, EGFR, HTR2A, INSR, MET, PTGS2, SIGMAR1, SRC, TEK |
3.85414 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CDC25B, CES1, CES2, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, HTR2A, HTR5A, IDO1, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PTGES, PTGS2, PTPN1, RELA, SIGMAR1, SLC6A4, SMAD3, SRC, TERT, TYR, XDH |
3.60766 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.3993 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, EGFR, HSD17B2, HSD17B3, PTGES, PTGS2, SIGMAR1 |
3.07466 |
[CC] GO:0005901 |
caveola
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
2.85047 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.69705 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CHRM2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, PTGS2, SLC6A2, SLC6A4, SRC |
2.66404 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CACNA1C, CES1, CES2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B3, HSPA1A, HTR2A, HTR5A, HTR6, IDO1, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SIGMAR1, SMAD3, SRC, TERT, TYR, XDH |
2.5857 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, HTR6, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.55985 |
[CC] GO:0044853 |
plasma membrane raft
|
ADRA1A, HTR2A, INSR, PTGS2, SRC |
2.41903 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B3, HSPA1A, HTR2A, HTR5A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SIGMAR1, SMAD3, SRC, TERT, TYR, XDH |
2.41428 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, HTR2A, HTR2B, HTR5A, HTR6, PTGS2, SLC6A2, SLC6A4, SRC, TEK |
2.40496 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CACNA1C, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MAOA, MET, PTGES, SIGMAR1, SLC6A2, SLC6A4, TEK, TYR |
2.13426 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CACNA1C, CHRM2, CNR1, CNR2, DRD2, HTR2A, HTR2B, HTR5A, IDO1, INSR, PTGS2, SIGMAR1, SLC6A2, SLC6A4, SRC |
2.09889 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
15.7937 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
15.7766 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GSK3B, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
15.0051 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
12.9956 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, PPARA, RORC, SIGMAR1, SMAD3, TEK |
12.4951 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
11.5734 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AR, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, SIGMAR1, TEK |
11.2131 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
10.4025 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, EGFR, FLT3, GSK3B, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, SIGMAR1, SLC6A4, SRC, TEK |
10.3703 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.9024 |
[MF] GO:0008227 |
None
|
ADRA1A, ADRA2A, CHRM2, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
9.78653 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, SLC6A4 |
8.80552 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
8.7116 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DUSP3, EGFR, F3, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTGS2, PTPN1, SRC, TEK, TERT, TYR, XDH |
8.68331 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
8.24431 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, ADRA2A, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
8.24431 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.94861 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, IDO1, PTGS2, SRC |
7.89 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
7.61941 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, IDO1, PTGS2, SRC |
7.57118 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.34819 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, XDH |
6.97391 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, HSD17B2, HSD17B3, IDO1, MAOA, PTGS2, TYR, XDH |
6.91717 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.86676 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.81582 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
6.67572 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.66509 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.66509 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.66124 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.56127 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.56127 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
6.40664 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.16545 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.16545 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.0682 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS2, TYR |
6.06689 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, IDO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.03391 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.67984 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.64357 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, IDO1, PTGES, PTGS2, SRC, XDH |
5.59178 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.48683 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.45117 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
5.42951 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, ADRA2A, CHRM2, CNR1, CNR2, DRD1, DRD2, DRD3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
5.10884 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.01732 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, HTR2A, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
4.96951 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.6542 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, RORC, SHBG |
4.61737 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SHBG, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.5322 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.44107 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.97444 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, BCL2, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, PTGS2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
3.93467 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3 |
3.7432 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HSPA1A, KCNH2, MET, PPARA, PTGS2, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK |
3.72676 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TERT |
3.67581 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, IGF1R, INSR, SHBG |
3.54418 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.24538 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA1A, ADRA2A, AOX1, AR, AXL, BCL2, DRD2, EGFR, FLT3, KCNH2, PTGS2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
3.04239 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.02659 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.92277 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.92277 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.9013 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IDO1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTGS2, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.87435 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.8075 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
2.77757 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, RELA, SMAD3, SRC, TERT |
2.69705 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, KCNH2, PTGS2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
2.66404 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA1A, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DHFR, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPR35, GSK3B, HCAR2, HSD17B2, HSD17B3, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IDO1, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTGS2, PTPN1, RELA, RORC, SHBG, SIGMAR1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
2.6163 |
[MF] GO:0008013 |
beta-catenin binding
|
AR, CSNK2A1, ESR1, GSK3B, SMAD3 |
2.59378 |
[MF] GO:0004935 |
None
|
ADRA1A, ADRA2A, DRD2 |
2.56169 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B2, HSD17B3, XDH |
2.55467 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.53423 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.52938 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.52938 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.52938 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.49969 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.49969 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.307 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.27247 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.27247 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.27247 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.27247 |
[MF] GO:0031625 |
None
|
BCL2, EGFR, GSK3B, HSPA1A, KCNH2, RELA, SMAD3, SRC |
2.27212 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, PPARA, RORC, SHBG |
2.22453 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.1839 |
[MF] GO:0044389 |
None
|
BCL2, EGFR, GSK3B, HSPA1A, KCNH2, RELA, SMAD3, SRC |
2.16126 |
[MF] GO:0047485 |
None
|
CSNK2A1, HSPA1A, MAP2K1, RELA, TERT |
2.15762 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRA1A, ADRA2A, AXL, BCL2, DRD2, EGFR, RELA, SMAD3, TYR |
2.12482 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.09522 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.09522 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.02843 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.02615 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.02086 |
[MF] GO:0001085 |
RNA polymerase II transcription factor binding
|
AR, ESR1, GSK3B, PPARA, SMAD3 |
2.00806 |